Washington Trust Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,892
Closed -$376K 216
2022
Q2
$376K Sell
4,892
-6,345
-56% -$483K 0.05% 153
2022
Q1
$821K Sell
11,237
-3,663
-25% -$246K 0.1% 105
2021
Q4
$929K Buy
14,900
+1,598
+12% +$93.7K 0.09% 98
2021
Q3
$787K Buy
13,302
+4,967
+60% +$327K 0.09% 100
2021
Q2
$557K Sell
8,335
-3,087
-27% -$201K 0.07% 114
2021
Q1
$721K Sell
11,422
-2,663
-19% -$166K 0.09% 108
2020
Q4
$873K Buy
14,085
+226
+2% +$13.9K 0.11% 100
2020
Q3
$835K Sell
13,859
-1,169
-8% -$70.4K 0.12% 95
2020
Q2
$884K Sell
15,028
-281
-2% -$16.8K 0.14% 90
2020
Q1
$853K Buy
15,309
+5,341
+54% +$326K 0.16% 82
2019
Q4
$640K Buy
9,968
+3,006
+43% +$172K 0.09% 116
2019
Q3
$353K Buy
6,962
+1,978
+40% +$93K 0.06% 137
2019
Q2
$226K Sell
4,984
-440
-8% -$20.5K 0.04% 177
2019
Q1
$259K Hold
5,424
0.04% 169
2018
Q4
$282K Sell
5,424
-333
-6% -$17.9K 0.04% 181
2018
Q3
$357K Buy
5,757
+39
+0.7% +$2.31K 0.05% 164
2018
Q2
$317K Hold
5,718
0.04% 181
2018
Q1
$362K Hold
5,718
0.05% 167
2017
Q4
$351K Sell
5,718
-226
-4% -$14.1K 0.05% 173
2017
Q3
$379K Buy
5,944
+226
+4% +$13.2K 0.06% 152
2017
Q2
$319K Sell
5,718
-1,005
-15% -$54.7K 0.07% 157
2017
Q1
$366K Sell
6,723
-4,311
-39% -$236K 0.08% 141
2016
Q4
$645K Sell
11,034
-77
-0.7% -$4.21K 0.15% 101
2016
Q3
$599K Buy
11,111
+158
+1% +$10.1K 0.14% 101
2016
Q2
$806K Sell
10,953
-53
-0.5% -$3.75K 0.21% 82
2016
Q1
$703K Sell
11,006
-680
-6% -$42.9K 0.18% 90
2015
Q4
$804K Sell
11,686
-775
-6% -$51.2K 0.18% 97
2015
Q3
$738K Buy
12,461
+1,760
+16% +$112K 0.2% 99
2015
Q2
$712K Sell
10,701
-652
-6% -$43K 0.17% 97
2015
Q1
$732K Hold
11,353
0.18% 97
2014
Q4
$670K Sell
11,353
-689
-6% -$38.9K 0.17% 115
2014
Q3
$616K Sell
12,042
-686
-5% -$34.3K 0.19% 109
2014
Q2
$617K Sell
12,728
-875
-6% -$43.1K 0.13% 118
2014
Q1
$707K Buy
13,603
+12,853
+1,714% +$684K 0.15% 101
2013
Q4
$275 Sell
750
-4,417
-85% -$225K 0.5% 95
2013
Q3
$239K Buy
+5,167
New +$227K 0.06% 155

Other funds holding BMY

Washington Trust Bank's BMY Position: Q3 2022 in Review

Washington Trust Bank sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 4,892 shares — an estimated $376K sold.

Washington Trust Bank first reported a position in BMY in Q3 2013 and held it in 36 quarters. The position peaked at $929K in Q4 2021. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Washington Trust Bank reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Washington Trust Bank sold 4,892 Bristol-Myers Squibb shares in Q3 2022, an estimated $376K.
  • Washington Trust Bank first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 36 quarters.
  • Washington Trust Bank's Bristol-Myers Squibb position peaked at $929K in Q4 2021.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Washington Trust Bank's 13F filing for Q3 2022, filed 16 Nov 2022.